Continuous variables | Mean +/- SD |
---|---|
Age in years | 83.9+/-7.2 |
Categorical variables | Percentage |
Gender (% women) | 77.2% |
Country of birthc (% Australia) | 81.4% |
Main language spokenc (% English) | 93.5% |
Body mass indexd in kg/m2 | 24.6+/-3.6 |
Pre-injury living statusc (% at home along) | 43.5% |
Pre-injury mobilityc (% independent) | 69.4% |
Pre-injury personal ADLsc (% independent) | 64.8% |
Pre-injury modified Barthel index | 87.09+/-21.04 |
Pre-injury functional comorbidity index | 3.12+/-1.95 |
Comorbidity present: | |
Arthritis | 49.1% |
Osteoporosis | 45.4% |
Gastrointestinal | 27.4% |
Visual impairment | 27.3% |
Hip fracture subtypee | - Undisplaced subcapital: 4.3% |
- Displaced subcapital: 46.7% | |
- Pertrochanteric simple (2-part): 4.3% | |
- Pertrochanteric complex (3-part): 29.0% | |
- Intertrochanteric/basicervical: 6.7% | |
- Subtrochanteric: 9.0% | |
Hip fracture surgerye | - Cannulated screws: 2.4% |
- Uncemented hemiarthroplasty: 13.7% | |
- Cemented hemiarthroplasty: 8.1% | |
- Total hip replacement: 18.5% | |
- Dynamic hip screw with short plate: 10.4% | |
- Dynamic hip screw with long plate: 18.5% | |
- Gamma nail: 28.4% | |
MMSE score (c) | 26.0+/-4.35 |
Using calcium (e) | 10.4% |
Using vitamin D (e) | 10.3% |
Using other osteoporosis medications (b) | 29.9% |
Using psychotropic medication (e) | 32.7% |
Using antihypertensive medication (e) | 54.2% |
25-hydroxyvitamin D level (f) | 52.7+/-23.5 nmol/L |
Serum corrected calcium (e) | 2.31+/-0.13 mmol/L |
Grip strength (e) | 16.1+/-6.8 kgs |